Wrist Biosensor + mHealth App for HIV/AIDS

(SHARE Engage Trial)

Recruiting at 2 trial locations

Overseen By Yan Wang, PhD

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Florida State University

Disqualifiers: Pregnant, Prisoners, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

66 Participants Needed

Trial Summary

What is the purpose of this trial?

In this study, participants will be asked to wear a wrist alcohol biosensor for 30 days and report alcohol use using a ecological momentary assessment (EMA) app. A subset of the sample will be micro-randomized to test two engagement strategies--reciprocity and personalized feedback via the eWrapper app to promote their engagement with the biosensor.

Eligibility Criteria

This trial is for young people living with HIV in Florida, aged 18-29, who have had a drink in the last month. They must understand English, be able to give informed consent, and have internet access. It's not for prisoners, those unable to consent or individuals without an HIV diagnosis.

Inclusion Criteria

I have been diagnosed with HIV.

Have internet access via smartphone, tablet or computer

Currently reside in Florida

Exclusion Criteria

You are pregnant.

I am unable to give consent for medical procedures.

Women who are pregnant may participate in the study.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants wear a wrist alcohol biosensor and report alcohol use using an EMA app for 30 days. A subset is micro-randomized to test engagement strategies.

4 weeks

Follow-up

Participants are monitored for alcohol biomarker (PEth) at 1-month follow-up.

4 weeks

Treatment Details

Interventions

• eWrapper-Engagement strategies to facilitate alcohol biosensor wearing

Trial Overview Participants will wear a wrist alcohol biosensor for a month and use an app to report their drinking. The study tests if 'reciprocity' (exchanging things with others) and personalized feedback through the app can increase engagement with the biosensor.

Participant Groups

Group I: Engagement in biosensor wearing Experimental Treatment 1 Intervention

A subset of the participants will receive the same interventions, namely the reciprocity messages, personalized feedback, or no prompt (as control condition), using micro-randomization procedure that randomly assign one of the condition in the morning and one of the condition in the evening.

Who Is Running the Clinical Trial?

Florida State University

Lead Sponsor

Trials

234

Recruited

41,100+

University of Florida

Collaborator

Trials

1,428

Recruited

987,000+

University of Michigan

Collaborator

Trials

1,891

Recruited

6,458,000+